Introduction of PSA screening will increase total healthcare costs for prostate cancer substantially, of which the actual screening costs will be a small part.
In the case of prostate cancer screening, two systematic reviews have concluded that screening should not be carried out.
In general, this recommendation has been accepted in the United Kingdom.
.
